Categories
Life Sciences Consumer Goods Materials and Chemicals Construction & Manufacturing Food and Beverages Energy and Power Semiconductor and Electronics Automotive and Transportation ICT & Media Aerospace & Defense BFSI

Int'l : +1-503-894-6022 | Toll Free : +1-800-792-5285 | help@alliedmarketresearch.com

Occlusion Devices Market by Product (Occlusion Removal Devices, Embolization Devices, Support Devices), by Application (Neurology, Cardiology, Peripheral Vascular Diseases, Urology, Oncology, Gynecology) and by End User (Hospitals, Diagnostic Centers, Surgical Centers, Ambulatory Care Centers, Research Laboratories Academic Institutes): Global Opportunity Analysis and Industry Forecast, 2023-2032

A09090

Pages: NA

Charts: NA

Tables: NA

Occlusion Devices Market Outlook - 2027    

Occlusion Devices Market is expected to grow in upcoming years due to factors such as rise in prevalence of heart related diseases and increase in demand for diagnosis and treatment of these diseases.

Occlusion in medical terms refers to blockage of blood vessels or hollow organs. Occlusion devices are medical deices which are used in treatment of several defects in the body of patient. Defects including cardiovascular, neurological, gynecological, oncological can be treated using the occlusion devices. The devices used for occlusion treatment are clinically tested and are effective for removing the occlusion from different parts of the body.

COVID-19 scenario analysis:

To take care of infected population the demand for medical supplies is increasing. Respiratory support devices such as atomizer, life-support machine, oxygen generator, and monitor are among the majorly used medical devices in primary clinical treatment. Moreover, COVID-19 has led to a huge surge in demand for medical supplies such as personal protective equipment including masks, gloves, and protective eyeglasses. With rise in number of COVID-19 cases worldwide, the need for medical supplies keeps on rising among, both from healthcare professionals and civil population for precautionary measures. Manufacturers of these products have a chance to capitalize this increased demand of medical supplies to ensure adequate and continuous supply of personal protective equipment in the market. Considering these factors, COVID -19 is expected to have significant impact on Occlusion Devices Market.

Top Impacting factors:

  • Factors such increase in target population for the device usage and rise in prevalence and adoption of minimal invasive surgical procedures is expected to boost the market growth for occlusion devices market.
  • Effective reimbursement policies regarding occlusion devices is one of the factors responsible for market growth.
  • Increased expansion level for distribution and manufacturing of these devices in developing countries is expected to rise the occlusion devices market growth.
  • However, limitations in procedure of CTO (chronic total occlusion) treatment, stringent regulations and compliances regarding approval of the occlusion devices for commercialization is expected to hinder the growth of market up to some extent over the forecast period.
  • Scarcity of skilled professionals for minimally invasive procedures will restrain the market growth till some extent.

New Product Launch / News:

  • In 2019, After receiving FDA clearance, Okami Medical announced the first use of LOBO on a patient in March. The LOBO (Low-Profile Braided Occluder) system’s creators designed it to provide interventional physicians with a single-device, one-and-done solution for the occlusion of various arterial targets without the need for multiple embolic devices.
  • In July 2019, Avinger announced the commercial availability of “Ocelot” for the Australia region. “Ocelot” is an image-guided chronic total occlusion crossing system and has completed the registration with the “Therapeutic Goods Administration (TGA)” and has been permitted to be distributed throughout Australia.
  • In May 2018, Abbott announced the availability of real-world results for their “AMPLATZER Amulet left atrial appendage (LAA) occlusion device” for patients suffering from atrial fibrillation. The results indicated that the device helped in the overall reduction of stroke risk, transient ischemic attack and systemic embolism, not requiring blood-thinners.

Key benefits of the report:

  • This study presents the analytical depiction of the Occlusion Devices Market along with the current trends and future estimations to determine the investments.
  • The report presents information related to key drivers, restraints, and opportunities along with detailed analysis of the Market share.
  • The current market is quantitatively analyzed to highlight the Market growth scenario.
  • Porter’s five forces analysis illustrates the potency of buyers & suppliers in the market.
  • The report provides a detailed Occlusion Devices Market analysis based on competitive intensity and how the competition will take shape in coming years.

Questions answered in the Occlusion Devices Market Report:

  • What are the leading market players active in Occlusion Devices Market?
  • What the current trends will influence the market in the next few years?
  • What are the driving factors, restraints, and opportunities in the market?
  • What are the projections for the future that would help in taking further strategic steps?
  • What Segments and region will drive the market growth & why?

 Key Market Segments

  • By Product
    • Occlusion Removal Devices
      • Stent Retrievers
      • Coil Retrievers
      • Balloon Occlusion Devices
      • Suction & Aspiration Devices
    • Embolization Devices
      • Embolic Coils
      • Liquid Embolic Agents
      • Tubal Occlusion Devices
    • Support Devices
      • Microcatheters
      • Guidewires
  • By Application
    • Neurology
    • Cardiology
    • Peripheral Vascular Diseases
    • Urology
    • Oncology
    • Gynecology
  • By End User
    • Hospitals, Diagnostic Centers, & Surgical Centers
    • Ambulatory Care Centers
    • Research Laboratories & Academic Institutes
  • By Region
    • North America
      • U.S.
      • Canada
      • Mexico
    • Europe
      • Germany
      • France
      • UK
      • Spain
      • Italy
      • Rest of Europe
    • Asia-Pacific
      • China
      • India
      • Japan
      • Australia
      • Rest of Asia-Pacific
    • LAMEA
      • Brazil
      • South Africa
      • Saudi Arabia
      • Rest of LAMEA

 
Key Market Players

  • Boston Scientific Corporation
  • DePuy Synthes
  • Penumbra
  • Medtronic
  • Meril Life Sciences Pvt. Ltd
  • Terumo
  • Acrostak Int. Distr. Sàrl
  • ASAHI INTECC CO
  • Abbott
  • Boston Scientific
  • KYOTO MEDICAL
  • Stryker Corporation

  • CHAPTER 1: INTRODUCTION

    • 1.1. Report Description

    • 1.2. Key Market Segments

    • 1.3. Key Benefits

    • 1.4. Research Methodology

      • 1.4.1. Primary Research

      • 1.4.2. Secondary Research

      • 1.4.3. Analyst Tools and Models

  • CHAPTER 2: EXECUTIVE SUMMARY

    • 2.1. CXO Perspective

  • CHAPTER 3: MARKET LANDSCAPE

    • 3.1. Market Definition and Scope

    • 3.2. Key Findings

      • 3.2.1. Top Investment Pockets

      • 3.2.2. Top Winning Strategies

    • 3.3. Porter's Five Forces Analysis

      • 3.3.1. Bargaining Power of Suppliers

      • 3.3.2. Threat of New Entrants

      • 3.3.3. Threat of Substitutes

      • 3.3.4. Competitive Rivalry

      • 3.3.5. Bargaining Power among Buyers

    • 3.5. Market Dynamics

      • 3.5.1. Drivers

      • 3.5.2. Restraints

      • 3.5.3. Opportunities

  • CHAPTER 4: OCCLUSION DEVICES MARKET, BY PRODUCT

    • 4.1. Market Overview

      • 4.1.1 Market Size and Forecast, By Product

    • 4.2. Occlusion Removal Devices

      • 4.2.1. Key Market Trends, Growth Factors and Opportunities

      • 4.2.2. Market Size and Forecast, By Region

      • 4.2.3. Market Share Analysis, By Country

      • 4.2.4. Stent Retrievers

        • 4.2.4.1. Market Size and Forecast

      • 4.2.4. Coil Retrievers

        • 4.2.4.1. Market Size and Forecast

      • 4.2.4. Balloon Occlusion Devices

        • 4.2.4.1. Market Size and Forecast

      • 4.2.4. Suction and Aspiration Devices

        • 4.2.4.1. Market Size and Forecast

    • 4.3. Embolization Devices

      • 4.3.1. Key Market Trends, Growth Factors and Opportunities

      • 4.3.2. Market Size and Forecast, By Region

      • 4.3.3. Market Share Analysis, By Country

      • 4.3.4. Embolic Coils

        • 4.3.4.1. Market Size and Forecast

      • 4.3.4. Liquid Embolic Agents

        • 4.3.4.1. Market Size and Forecast

      • 4.3.4. Tubal Occlusion Devices

        • 4.3.4.1. Market Size and Forecast

    • 4.4. Support Devices

      • 4.4.1. Key Market Trends, Growth Factors and Opportunities

      • 4.4.2. Market Size and Forecast, By Region

      • 4.4.3. Market Share Analysis, By Country

      • 4.4.4. Microcatheters

        • 4.4.4.1. Market Size and Forecast

      • 4.4.4. Guidewires

        • 4.4.4.1. Market Size and Forecast

  • CHAPTER 5: OCCLUSION DEVICES MARKET, BY APPLICATION

    • 5.1. Market Overview

      • 5.1.1 Market Size and Forecast, By Application

    • 5.2. Neurology

      • 5.2.1. Key Market Trends, Growth Factors and Opportunities

      • 5.2.2. Market Size and Forecast, By Region

      • 5.2.3. Market Share Analysis, By Country

    • 5.3. Cardiology

      • 5.3.1. Key Market Trends, Growth Factors and Opportunities

      • 5.3.2. Market Size and Forecast, By Region

      • 5.3.3. Market Share Analysis, By Country

    • 5.4. Peripheral Vascular Diseases

      • 5.4.1. Key Market Trends, Growth Factors and Opportunities

      • 5.4.2. Market Size and Forecast, By Region

      • 5.4.3. Market Share Analysis, By Country

    • 5.5. Urology

      • 5.5.1. Key Market Trends, Growth Factors and Opportunities

      • 5.5.2. Market Size and Forecast, By Region

      • 5.5.3. Market Share Analysis, By Country

    • 5.6. Oncology

      • 5.6.1. Key Market Trends, Growth Factors and Opportunities

      • 5.6.2. Market Size and Forecast, By Region

      • 5.6.3. Market Share Analysis, By Country

    • 5.7. Gynecology

      • 5.7.1. Key Market Trends, Growth Factors and Opportunities

      • 5.7.2. Market Size and Forecast, By Region

      • 5.7.3. Market Share Analysis, By Country

  • CHAPTER 6: OCCLUSION DEVICES MARKET, BY END USER

    • 6.1. Market Overview

      • 6.1.1 Market Size and Forecast, By End User

    • 6.2. Hospitals, Diagnostic Centers, And Surgical Centers

      • 6.2.1. Key Market Trends, Growth Factors and Opportunities

      • 6.2.2. Market Size and Forecast, By Region

      • 6.2.3. Market Share Analysis, By Country

    • 6.3. Ambulatory Care Centers

      • 6.3.1. Key Market Trends, Growth Factors and Opportunities

      • 6.3.2. Market Size and Forecast, By Region

      • 6.3.3. Market Share Analysis, By Country

    • 6.4. Research Laboratories And Academic Institutes

      • 6.4.1. Key Market Trends, Growth Factors and Opportunities

      • 6.4.2. Market Size and Forecast, By Region

      • 6.4.3. Market Share Analysis, By Country

  • CHAPTER 7: OCCLUSION DEVICES MARKET, BY REGION

    • 7.1. Market Overview

      • 7.1.1 Market Size and Forecast, By Region

    • 7.2. North America

      • 7.2.1. Key Market Trends and Opportunities

      • 7.2.2. Market Size and Forecast, By Product

      • 7.2.3. Market Size and Forecast, By Application

      • 7.2.4. Market Size and Forecast, By End User

      • 7.2.5. Market Size and Forecast, By Country

      • 7.2.6. U.S. Occlusion Devices Market

        • 7.2.6.1. Market Size and Forecast, By Product
        • 7.2.6.2. Market Size and Forecast, By Application
        • 7.2.6.3. Market Size and Forecast, By End User

      • 7.2.7. Canada Occlusion Devices Market

        • 7.2.7.1. Market Size and Forecast, By Product
        • 7.2.7.2. Market Size and Forecast, By Application
        • 7.2.7.3. Market Size and Forecast, By End User

      • 7.2.8. Mexico Occlusion Devices Market

        • 7.2.8.1. Market Size and Forecast, By Product
        • 7.2.8.2. Market Size and Forecast, By Application
        • 7.2.8.3. Market Size and Forecast, By End User

    • 7.3. Europe

      • 7.3.1. Key Market Trends and Opportunities

      • 7.3.2. Market Size and Forecast, By Product

      • 7.3.3. Market Size and Forecast, By Application

      • 7.3.4. Market Size and Forecast, By End User

      • 7.3.5. Market Size and Forecast, By Country

      • 7.3.6. France Occlusion Devices Market

        • 7.3.6.1. Market Size and Forecast, By Product
        • 7.3.6.2. Market Size and Forecast, By Application
        • 7.3.6.3. Market Size and Forecast, By End User

      • 7.3.7. Germany Occlusion Devices Market

        • 7.3.7.1. Market Size and Forecast, By Product
        • 7.3.7.2. Market Size and Forecast, By Application
        • 7.3.7.3. Market Size and Forecast, By End User

      • 7.3.8. Italy Occlusion Devices Market

        • 7.3.8.1. Market Size and Forecast, By Product
        • 7.3.8.2. Market Size and Forecast, By Application
        • 7.3.8.3. Market Size and Forecast, By End User

      • 7.3.9. Spain Occlusion Devices Market

        • 7.3.9.1. Market Size and Forecast, By Product
        • 7.3.9.2. Market Size and Forecast, By Application
        • 7.3.9.3. Market Size and Forecast, By End User

      • 7.3.10. UK Occlusion Devices Market

        • 7.3.10.1. Market Size and Forecast, By Product
        • 7.3.10.2. Market Size and Forecast, By Application
        • 7.3.10.3. Market Size and Forecast, By End User

      • 7.3.11. Russia Occlusion Devices Market

        • 7.3.11.1. Market Size and Forecast, By Product
        • 7.3.11.2. Market Size and Forecast, By Application
        • 7.3.11.3. Market Size and Forecast, By End User

      • 7.3.12. Rest Of Europe Occlusion Devices Market

        • 7.3.12.1. Market Size and Forecast, By Product
        • 7.3.12.2. Market Size and Forecast, By Application
        • 7.3.12.3. Market Size and Forecast, By End User

    • 7.4. Asia-Pacific

      • 7.4.1. Key Market Trends and Opportunities

      • 7.4.2. Market Size and Forecast, By Product

      • 7.4.3. Market Size and Forecast, By Application

      • 7.4.4. Market Size and Forecast, By End User

      • 7.4.5. Market Size and Forecast, By Country

      • 7.4.6. China Occlusion Devices Market

        • 7.4.6.1. Market Size and Forecast, By Product
        • 7.4.6.2. Market Size and Forecast, By Application
        • 7.4.6.3. Market Size and Forecast, By End User

      • 7.4.7. Japan Occlusion Devices Market

        • 7.4.7.1. Market Size and Forecast, By Product
        • 7.4.7.2. Market Size and Forecast, By Application
        • 7.4.7.3. Market Size and Forecast, By End User

      • 7.4.8. India Occlusion Devices Market

        • 7.4.8.1. Market Size and Forecast, By Product
        • 7.4.8.2. Market Size and Forecast, By Application
        • 7.4.8.3. Market Size and Forecast, By End User

      • 7.4.9. South Korea Occlusion Devices Market

        • 7.4.9.1. Market Size and Forecast, By Product
        • 7.4.9.2. Market Size and Forecast, By Application
        • 7.4.9.3. Market Size and Forecast, By End User

      • 7.4.10. Australia Occlusion Devices Market

        • 7.4.10.1. Market Size and Forecast, By Product
        • 7.4.10.2. Market Size and Forecast, By Application
        • 7.4.10.3. Market Size and Forecast, By End User

      • 7.4.11. Thailand Occlusion Devices Market

        • 7.4.11.1. Market Size and Forecast, By Product
        • 7.4.11.2. Market Size and Forecast, By Application
        • 7.4.11.3. Market Size and Forecast, By End User

      • 7.4.12. Malaysia Occlusion Devices Market

        • 7.4.12.1. Market Size and Forecast, By Product
        • 7.4.12.2. Market Size and Forecast, By Application
        • 7.4.12.3. Market Size and Forecast, By End User

      • 7.4.13. Indonesia Occlusion Devices Market

        • 7.4.13.1. Market Size and Forecast, By Product
        • 7.4.13.2. Market Size and Forecast, By Application
        • 7.4.13.3. Market Size and Forecast, By End User

      • 7.4.14. Rest of Asia Pacific Occlusion Devices Market

        • 7.4.14.1. Market Size and Forecast, By Product
        • 7.4.14.2. Market Size and Forecast, By Application
        • 7.4.14.3. Market Size and Forecast, By End User

    • 7.5. LAMEA

      • 7.5.1. Key Market Trends and Opportunities

      • 7.5.2. Market Size and Forecast, By Product

      • 7.5.3. Market Size and Forecast, By Application

      • 7.5.4. Market Size and Forecast, By End User

      • 7.5.5. Market Size and Forecast, By Country

      • 7.5.6. Brazil Occlusion Devices Market

        • 7.5.6.1. Market Size and Forecast, By Product
        • 7.5.6.2. Market Size and Forecast, By Application
        • 7.5.6.3. Market Size and Forecast, By End User

      • 7.5.7. South Africa Occlusion Devices Market

        • 7.5.7.1. Market Size and Forecast, By Product
        • 7.5.7.2. Market Size and Forecast, By Application
        • 7.5.7.3. Market Size and Forecast, By End User

      • 7.5.8. Saudi Arabia Occlusion Devices Market

        • 7.5.8.1. Market Size and Forecast, By Product
        • 7.5.8.2. Market Size and Forecast, By Application
        • 7.5.8.3. Market Size and Forecast, By End User

      • 7.5.9. UAE Occlusion Devices Market

        • 7.5.9.1. Market Size and Forecast, By Product
        • 7.5.9.2. Market Size and Forecast, By Application
        • 7.5.9.3. Market Size and Forecast, By End User

      • 7.5.10. Argentina Occlusion Devices Market

        • 7.5.10.1. Market Size and Forecast, By Product
        • 7.5.10.2. Market Size and Forecast, By Application
        • 7.5.10.3. Market Size and Forecast, By End User

      • 7.5.11. Rest of LAMEA Occlusion Devices Market

        • 7.5.11.1. Market Size and Forecast, By Product
        • 7.5.11.2. Market Size and Forecast, By Application
        • 7.5.11.3. Market Size and Forecast, By End User

  • CHAPTER 8: COMPETITIVE LANDSCAPE

    • 8.1. Introduction

    • 8.2. Top Winning Strategies

    • 8.3. Product Mapping Of Top 10 Player

    • 8.4. Competitive Dashboard

    • 8.5. Competitive Heatmap

    • 8.6. Top Player Positioning, 2024

  • CHAPTER 9: COMPANY PROFILES

    • 9.1. Boston Scientific

      • 9.1.1. Company Overview

      • 9.1.2. Key Executives

      • 9.1.3. Company Snapshot

      • 9.1.4. Operating Business Segments

      • 9.1.5. Product Portfolio

      • 9.1.6. Business Performance

      • 9.1.7. Key Strategic Moves and Developments

    • 9.2. Medtronic

      • 9.2.1. Company Overview

      • 9.2.2. Key Executives

      • 9.2.3. Company Snapshot

      • 9.2.4. Operating Business Segments

      • 9.2.5. Product Portfolio

      • 9.2.6. Business Performance

      • 9.2.7. Key Strategic Moves and Developments

    • 9.3. Stryker Corporation

      • 9.3.1. Company Overview

      • 9.3.2. Key Executives

      • 9.3.3. Company Snapshot

      • 9.3.4. Operating Business Segments

      • 9.3.5. Product Portfolio

      • 9.3.6. Business Performance

      • 9.3.7. Key Strategic Moves and Developments

    • 9.4. Terumo

      • 9.4.1. Company Overview

      • 9.4.2. Key Executives

      • 9.4.3. Company Snapshot

      • 9.4.4. Operating Business Segments

      • 9.4.5. Product Portfolio

      • 9.4.6. Business Performance

      • 9.4.7. Key Strategic Moves and Developments

    • 9.5. Penumbra

      • 9.5.1. Company Overview

      • 9.5.2. Key Executives

      • 9.5.3. Company Snapshot

      • 9.5.4. Operating Business Segments

      • 9.5.5. Product Portfolio

      • 9.5.6. Business Performance

      • 9.5.7. Key Strategic Moves and Developments

    • 9.6. KYOTO MEDICAL

      • 9.6.1. Company Overview

      • 9.6.2. Key Executives

      • 9.6.3. Company Snapshot

      • 9.6.4. Operating Business Segments

      • 9.6.5. Product Portfolio

      • 9.6.6. Business Performance

      • 9.6.7. Key Strategic Moves and Developments

    • 9.7. Meril Life Sciences Pvt. Ltd

      • 9.7.1. Company Overview

      • 9.7.2. Key Executives

      • 9.7.3. Company Snapshot

      • 9.7.4. Operating Business Segments

      • 9.7.5. Product Portfolio

      • 9.7.6. Business Performance

      • 9.7.7. Key Strategic Moves and Developments

    • 9.8. DePuy Synthes

      • 9.8.1. Company Overview

      • 9.8.2. Key Executives

      • 9.8.3. Company Snapshot

      • 9.8.4. Operating Business Segments

      • 9.8.5. Product Portfolio

      • 9.8.6. Business Performance

      • 9.8.7. Key Strategic Moves and Developments

    • 9.9. Abbott

      • 9.9.1. Company Overview

      • 9.9.2. Key Executives

      • 9.9.3. Company Snapshot

      • 9.9.4. Operating Business Segments

      • 9.9.5. Product Portfolio

      • 9.9.6. Business Performance

      • 9.9.7. Key Strategic Moves and Developments

    • 9.10. Acrostak Int. Distr. Sàrl

      • 9.10.1. Company Overview

      • 9.10.2. Key Executives

      • 9.10.3. Company Snapshot

      • 9.10.4. Operating Business Segments

      • 9.10.5. Product Portfolio

      • 9.10.6. Business Performance

      • 9.10.7. Key Strategic Moves and Developments

    • 9.11. ASAHI INTECC CO

      • 9.11.1. Company Overview

      • 9.11.2. Key Executives

      • 9.11.3. Company Snapshot

      • 9.11.4. Operating Business Segments

      • 9.11.5. Product Portfolio

      • 9.11.6. Business Performance

      • 9.11.7. Key Strategic Moves and Developments

    • 9.12. Boston Scientific Corporation

      • 9.12.1. Company Overview

      • 9.12.2. Key Executives

      • 9.12.3. Company Snapshot

      • 9.12.4. Operating Business Segments

      • 9.12.5. Product Portfolio

      • 9.12.6. Business Performance

      • 9.12.7. Key Strategic Moves and Developments

  • LIST OF TABLES

  • TABLE 1. GLOBAL OCCLUSION DEVICES MARKET, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 2. GLOBAL OCCLUSION DEVICES MARKET FOR OCCLUSION REMOVAL DEVICES, BY REGION, 2025-2033 ($MILLION)
  • TABLE 3. GLOBAL OCCLUSION DEVICES MARKET FOR EMBOLIZATION DEVICES, BY REGION, 2025-2033 ($MILLION)
  • TABLE 4. GLOBAL OCCLUSION DEVICES MARKET FOR SUPPORT DEVICES, BY REGION, 2025-2033 ($MILLION)
  • TABLE 5. GLOBAL OCCLUSION DEVICES MARKET, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 6. GLOBAL OCCLUSION DEVICES MARKET FOR NEUROLOGY, BY REGION, 2025-2033 ($MILLION)
  • TABLE 7. GLOBAL OCCLUSION DEVICES MARKET FOR CARDIOLOGY, BY REGION, 2025-2033 ($MILLION)
  • TABLE 8. GLOBAL OCCLUSION DEVICES MARKET FOR PERIPHERAL VASCULAR DISEASES, BY REGION, 2025-2033 ($MILLION)
  • TABLE 9. GLOBAL OCCLUSION DEVICES MARKET FOR UROLOGY, BY REGION, 2025-2033 ($MILLION)
  • TABLE 10. GLOBAL OCCLUSION DEVICES MARKET FOR ONCOLOGY, BY REGION, 2025-2033 ($MILLION)
  • TABLE 11. GLOBAL OCCLUSION DEVICES MARKET FOR GYNECOLOGY, BY REGION, 2025-2033 ($MILLION)
  • TABLE 12. GLOBAL OCCLUSION DEVICES MARKET, BY END USER, 2025-2033 ($MILLION)
  • TABLE 13. GLOBAL OCCLUSION DEVICES MARKET FOR HOSPITALS, DIAGNOSTIC CENTERS, AND SURGICAL CENTERS, BY REGION, 2025-2033 ($MILLION)
  • TABLE 14. GLOBAL OCCLUSION DEVICES MARKET FOR AMBULATORY CARE CENTERS, BY REGION, 2025-2033 ($MILLION)
  • TABLE 15. GLOBAL OCCLUSION DEVICES MARKET FOR RESEARCH LABORATORIES AND ACADEMIC INSTITUTES, BY REGION, 2025-2033 ($MILLION)
  • TABLE 16. GLOBAL OCCLUSION DEVICES MARKET, BY REGION, 2025-2033 ($MILLION)
  • TABLE 17. NORTH AMERICA OCCLUSION DEVICES, BY REGION, 2025-2033 ($MILLION)
  • TABLE 18. NORTH AMERICA OCCLUSION DEVICES, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 19. NORTH AMERICA OCCLUSION DEVICES, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 20. NORTH AMERICA OCCLUSION DEVICES, BY END USER, 2025-2033 ($MILLION)
  • TABLE 21. U.S. OCCLUSION DEVICES, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 22. U.S. OCCLUSION DEVICES, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 23. U.S. OCCLUSION DEVICES, BY END USER, 2025-2033 ($MILLION)
  • TABLE 24. CANADA OCCLUSION DEVICES, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 25. CANADA OCCLUSION DEVICES, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 26. CANADA OCCLUSION DEVICES, BY END USER, 2025-2033 ($MILLION)
  • TABLE 27. MEXICO OCCLUSION DEVICES, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 28. MEXICO OCCLUSION DEVICES, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 29. MEXICO OCCLUSION DEVICES, BY END USER, 2025-2033 ($MILLION)
  • TABLE 30. EUROPE OCCLUSION DEVICES, BY REGION, 2025-2033 ($MILLION)
  • TABLE 31. EUROPE OCCLUSION DEVICES, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 32. EUROPE OCCLUSION DEVICES, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 33. EUROPE OCCLUSION DEVICES, BY END USER, 2025-2033 ($MILLION)
  • TABLE 34. FRANCE OCCLUSION DEVICES, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 35. FRANCE OCCLUSION DEVICES, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 36. FRANCE OCCLUSION DEVICES, BY END USER, 2025-2033 ($MILLION)
  • TABLE 37. GERMANY OCCLUSION DEVICES, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 38. GERMANY OCCLUSION DEVICES, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 39. GERMANY OCCLUSION DEVICES, BY END USER, 2025-2033 ($MILLION)
  • TABLE 40. ITALY OCCLUSION DEVICES, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 41. ITALY OCCLUSION DEVICES, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 42. ITALY OCCLUSION DEVICES, BY END USER, 2025-2033 ($MILLION)
  • TABLE 43. SPAIN OCCLUSION DEVICES, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 44. SPAIN OCCLUSION DEVICES, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 45. SPAIN OCCLUSION DEVICES, BY END USER, 2025-2033 ($MILLION)
  • TABLE 46. UK OCCLUSION DEVICES, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 47. UK OCCLUSION DEVICES, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 48. UK OCCLUSION DEVICES, BY END USER, 2025-2033 ($MILLION)
  • TABLE 49. RUSSIA OCCLUSION DEVICES, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 50. RUSSIA OCCLUSION DEVICES, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 51. RUSSIA OCCLUSION DEVICES, BY END USER, 2025-2033 ($MILLION)
  • TABLE 52. REST OF EUROPE OCCLUSION DEVICES, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 53. REST OF EUROPE OCCLUSION DEVICES, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 54. REST OF EUROPE OCCLUSION DEVICES, BY END USER, 2025-2033 ($MILLION)
  • TABLE 55. ASIA-PACIFIC OCCLUSION DEVICES, BY REGION, 2025-2033 ($MILLION)
  • TABLE 56. ASIA-PACIFIC OCCLUSION DEVICES, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 57. ASIA-PACIFIC OCCLUSION DEVICES, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 58. ASIA-PACIFIC OCCLUSION DEVICES, BY END USER, 2025-2033 ($MILLION)
  • TABLE 59. CHINA OCCLUSION DEVICES, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 60. CHINA OCCLUSION DEVICES, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 61. CHINA OCCLUSION DEVICES, BY END USER, 2025-2033 ($MILLION)
  • TABLE 62. JAPAN OCCLUSION DEVICES, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 63. JAPAN OCCLUSION DEVICES, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 64. JAPAN OCCLUSION DEVICES, BY END USER, 2025-2033 ($MILLION)
  • TABLE 65. INDIA OCCLUSION DEVICES, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 66. INDIA OCCLUSION DEVICES, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 67. INDIA OCCLUSION DEVICES, BY END USER, 2025-2033 ($MILLION)
  • TABLE 68. SOUTH KOREA OCCLUSION DEVICES, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 69. SOUTH KOREA OCCLUSION DEVICES, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 70. SOUTH KOREA OCCLUSION DEVICES, BY END USER, 2025-2033 ($MILLION)
  • TABLE 71. AUSTRALIA OCCLUSION DEVICES, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 72. AUSTRALIA OCCLUSION DEVICES, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 73. AUSTRALIA OCCLUSION DEVICES, BY END USER, 2025-2033 ($MILLION)
  • TABLE 74. THAILAND OCCLUSION DEVICES, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 75. THAILAND OCCLUSION DEVICES, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 76. THAILAND OCCLUSION DEVICES, BY END USER, 2025-2033 ($MILLION)
  • TABLE 77. MALAYSIA OCCLUSION DEVICES, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 78. MALAYSIA OCCLUSION DEVICES, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 79. MALAYSIA OCCLUSION DEVICES, BY END USER, 2025-2033 ($MILLION)
  • TABLE 80. INDONESIA OCCLUSION DEVICES, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 81. INDONESIA OCCLUSION DEVICES, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 82. INDONESIA OCCLUSION DEVICES, BY END USER, 2025-2033 ($MILLION)
  • TABLE 83. REST OF ASIA PACIFIC OCCLUSION DEVICES, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 84. REST OF ASIA PACIFIC OCCLUSION DEVICES, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 85. REST OF ASIA PACIFIC OCCLUSION DEVICES, BY END USER, 2025-2033 ($MILLION)
  • TABLE 86. LAMEA OCCLUSION DEVICES, BY REGION, 2025-2033 ($MILLION)
  • TABLE 87. LAMEA OCCLUSION DEVICES, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 88. LAMEA OCCLUSION DEVICES, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 89. LAMEA OCCLUSION DEVICES, BY END USER, 2025-2033 ($MILLION)
  • TABLE 90. BRAZIL OCCLUSION DEVICES, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 91. BRAZIL OCCLUSION DEVICES, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 92. BRAZIL OCCLUSION DEVICES, BY END USER, 2025-2033 ($MILLION)
  • TABLE 93. SOUTH AFRICA OCCLUSION DEVICES, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 94. SOUTH AFRICA OCCLUSION DEVICES, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 95. SOUTH AFRICA OCCLUSION DEVICES, BY END USER, 2025-2033 ($MILLION)
  • TABLE 96. SAUDI ARABIA OCCLUSION DEVICES, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 97. SAUDI ARABIA OCCLUSION DEVICES, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 98. SAUDI ARABIA OCCLUSION DEVICES, BY END USER, 2025-2033 ($MILLION)
  • TABLE 99. UAE OCCLUSION DEVICES, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 100. UAE OCCLUSION DEVICES, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 101. UAE OCCLUSION DEVICES, BY END USER, 2025-2033 ($MILLION)
  • TABLE 102. ARGENTINA OCCLUSION DEVICES, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 103. ARGENTINA OCCLUSION DEVICES, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 104. ARGENTINA OCCLUSION DEVICES, BY END USER, 2025-2033 ($MILLION)
  • TABLE 105. REST OF LAMEA OCCLUSION DEVICES, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 106. REST OF LAMEA OCCLUSION DEVICES, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 107. REST OF LAMEA OCCLUSION DEVICES, BY END USER, 2025-2033 ($MILLION)
  • TABLE 108. BOSTON SCIENTIFIC: KEY EXECUTIVES
  • TABLE 109. BOSTON SCIENTIFIC: COMPANY SNAPSHOT
  • TABLE 110. BOSTON SCIENTIFIC: OPERATING SEGMENTS
  • TABLE 111. BOSTON SCIENTIFIC: PRODUCT PORTFOLIO
  • TABLE 112. BOSTON SCIENTIFIC: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 113. MEDTRONIC: KEY EXECUTIVES
  • TABLE 114. MEDTRONIC: COMPANY SNAPSHOT
  • TABLE 115. MEDTRONIC: OPERATING SEGMENTS
  • TABLE 116. MEDTRONIC: PRODUCT PORTFOLIO
  • TABLE 117. MEDTRONIC: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 118. STRYKER CORPORATION: KEY EXECUTIVES
  • TABLE 119. STRYKER CORPORATION: COMPANY SNAPSHOT
  • TABLE 120. STRYKER CORPORATION: OPERATING SEGMENTS
  • TABLE 121. STRYKER CORPORATION: PRODUCT PORTFOLIO
  • TABLE 122. STRYKER CORPORATION: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 123. TERUMO: KEY EXECUTIVES
  • TABLE 124. TERUMO: COMPANY SNAPSHOT
  • TABLE 125. TERUMO: OPERATING SEGMENTS
  • TABLE 126. TERUMO: PRODUCT PORTFOLIO
  • TABLE 127. TERUMO: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 128. PENUMBRA: KEY EXECUTIVES
  • TABLE 129. PENUMBRA: COMPANY SNAPSHOT
  • TABLE 130. PENUMBRA: OPERATING SEGMENTS
  • TABLE 131. PENUMBRA: PRODUCT PORTFOLIO
  • TABLE 132. PENUMBRA: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 133. KYOTO MEDICAL: KEY EXECUTIVES
  • TABLE 134. KYOTO MEDICAL: COMPANY SNAPSHOT
  • TABLE 135. KYOTO MEDICAL: OPERATING SEGMENTS
  • TABLE 136. KYOTO MEDICAL: PRODUCT PORTFOLIO
  • TABLE 137. KYOTO MEDICAL: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 138. MERIL LIFE SCIENCES PVT. LTD: KEY EXECUTIVES
  • TABLE 139. MERIL LIFE SCIENCES PVT. LTD: COMPANY SNAPSHOT
  • TABLE 140. MERIL LIFE SCIENCES PVT. LTD: OPERATING SEGMENTS
  • TABLE 141. MERIL LIFE SCIENCES PVT. LTD: PRODUCT PORTFOLIO
  • TABLE 142. MERIL LIFE SCIENCES PVT. LTD: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 143. DEPUY SYNTHES: KEY EXECUTIVES
  • TABLE 144. DEPUY SYNTHES: COMPANY SNAPSHOT
  • TABLE 145. DEPUY SYNTHES: OPERATING SEGMENTS
  • TABLE 146. DEPUY SYNTHES: PRODUCT PORTFOLIO
  • TABLE 147. DEPUY SYNTHES: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 148. ABBOTT: KEY EXECUTIVES
  • TABLE 149. ABBOTT: COMPANY SNAPSHOT
  • TABLE 150. ABBOTT: OPERATING SEGMENTS
  • TABLE 151. ABBOTT: PRODUCT PORTFOLIO
  • TABLE 152. ABBOTT: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 153. ACROSTAK INT. DISTR. SàRL: KEY EXECUTIVES
  • TABLE 154. ACROSTAK INT. DISTR. SàRL: COMPANY SNAPSHOT
  • TABLE 155. ACROSTAK INT. DISTR. SàRL: OPERATING SEGMENTS
  • TABLE 156. ACROSTAK INT. DISTR. SàRL: PRODUCT PORTFOLIO
  • TABLE 157. ACROSTAK INT. DISTR. SàRL: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 158. ASAHI INTECC CO: KEY EXECUTIVES
  • TABLE 159. ASAHI INTECC CO: COMPANY SNAPSHOT
  • TABLE 160. ASAHI INTECC CO: OPERATING SEGMENTS
  • TABLE 161. ASAHI INTECC CO: PRODUCT PORTFOLIO
  • TABLE 162. ASAHI INTECC CO: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 163. BOSTON SCIENTIFIC CORPORATION: KEY EXECUTIVES
  • TABLE 164. BOSTON SCIENTIFIC CORPORATION: COMPANY SNAPSHOT
  • TABLE 165. BOSTON SCIENTIFIC CORPORATION: OPERATING SEGMENTS
  • TABLE 166. BOSTON SCIENTIFIC CORPORATION: PRODUCT PORTFOLIO
  • TABLE 167. BOSTON SCIENTIFIC CORPORATION: KEY STRATEGIC MOVES AND DEVELOPMENTS

  • LIST OF FIGURES

  • FIGURE 1. GLOBAL OCCLUSION DEVICES MARKET SEGMENTATION
  • FIGURE 2. GLOBAL OCCLUSION DEVICES MARKET
  • FIGURE 3. SEGMENTATION OCCLUSION DEVICES MARKET
  • FIGURE 4. TOP INVESTMENT POCKET IN OCCLUSION DEVICES MARKET
  • FIGURE 5. MODERATE BARGAINING POWER OF BUYERS
  • FIGURE 6. MODERATE BARGAINING POWER OF SUPPLIERS
  • FIGURE 7. MODERATE THREAT OF NEW ENTRANTS
  • FIGURE 8. LOW THREAT OF SUBSTITUTION
  • FIGURE 9. HIGH COMPETITIVE RIVALRY
  • FIGURE 10. OPPORTUNITIES, RESTRAINTS AND DRIVERS: GLOBALOCCLUSION DEVICES MARKET
  • FIGURE 11. OCCLUSION DEVICES MARKET SEGMENTATION, BY BY PRODUCT
  • FIGURE 12. OCCLUSION DEVICES MARKET FOR OCCLUSION REMOVAL DEVICES, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 13. OCCLUSION DEVICES MARKET FOR EMBOLIZATION DEVICES, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 14. OCCLUSION DEVICES MARKET FOR SUPPORT DEVICES, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 15. OCCLUSION DEVICES MARKET SEGMENTATION, BY BY APPLICATION
  • FIGURE 16. OCCLUSION DEVICES MARKET FOR NEUROLOGY, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 17. OCCLUSION DEVICES MARKET FOR CARDIOLOGY, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 18. OCCLUSION DEVICES MARKET FOR PERIPHERAL VASCULAR DISEASES, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 19. OCCLUSION DEVICES MARKET FOR UROLOGY, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 20. OCCLUSION DEVICES MARKET FOR ONCOLOGY, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 21. OCCLUSION DEVICES MARKET FOR GYNECOLOGY, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 22. OCCLUSION DEVICES MARKET SEGMENTATION, BY BY END USER
  • FIGURE 23. OCCLUSION DEVICES MARKET FOR HOSPITALS, DIAGNOSTIC CENTERS, AND SURGICAL CENTERS, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 24. OCCLUSION DEVICES MARKET FOR AMBULATORY CARE CENTERS, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 25. OCCLUSION DEVICES MARKET FOR RESEARCH LABORATORIES AND ACADEMIC INSTITUTES, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 26. TOP WINNING STRATEGIES, BY YEAR, 2022-2024*
  • FIGURE 27. TOP WINNING STRATEGIES, BY DEVELOPMENT, 2022-2024*
  • FIGURE 28. TOP WINNING STRATEGIES, BY COMPANY, 2022-2024*
  • FIGURE 29. PRODUCT MAPPING OF TOP 10 PLAYERS
  • FIGURE 30. COMPETITIVE DASHBOARD
  • FIGURE 31. COMPETITIVE HEATMAP: OCCLUSION DEVICES MARKET
  • FIGURE 32. TOP PLAYER POSITIONING, 2024
  • FIGURE 33. BOSTON SCIENTIFIC: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 34. BOSTON SCIENTIFIC: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 35. BOSTON SCIENTIFIC: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 36. MEDTRONIC: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 37. MEDTRONIC: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 38. MEDTRONIC: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 39. STRYKER CORPORATION: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 40. STRYKER CORPORATION: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 41. STRYKER CORPORATION: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 42. TERUMO: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 43. TERUMO: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 44. TERUMO: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 45. PENUMBRA: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 46. PENUMBRA: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 47. PENUMBRA: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 48. KYOTO MEDICAL: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 49. KYOTO MEDICAL: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 50. KYOTO MEDICAL: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 51. MERIL LIFE SCIENCES PVT. LTD: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 52. MERIL LIFE SCIENCES PVT. LTD: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 53. MERIL LIFE SCIENCES PVT. LTD: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 54. DEPUY SYNTHES: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 55. DEPUY SYNTHES: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 56. DEPUY SYNTHES: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 57. ABBOTT: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 58. ABBOTT: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 59. ABBOTT: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 60. ACROSTAK INT. DISTR. SàRL: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 61. ACROSTAK INT. DISTR. SàRL: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 62. ACROSTAK INT. DISTR. SàRL: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 63. ASAHI INTECC CO: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 64. ASAHI INTECC CO: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 65. ASAHI INTECC CO: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 66. BOSTON SCIENTIFIC CORPORATION: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 67. BOSTON SCIENTIFIC CORPORATION: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 68. BOSTON SCIENTIFIC CORPORATION: REVENUE SHARE, BY REGION, 2024 (%)

Purchase Full Report of
Occlusion Devices Market

PURCHASE OPTIONS



* Taxes/Fees, If applicable will be added during checkout. All prices in USD.

Have a question ?

Need to add more ?

Avail up to 30% discount on subscription plans on


Avenue

© 2025 Allied Market Research. All Rights Reserved